Pharmacology: Although Clindamycin phosphate is inactive in vitro, rapid in vivo hydrolysis converts this compound to the antibacterially active Clindamycin. Clindamycin in vitro active to Propionibacterium acnes. Free fatty acids on the skin surface has been decreased from approximately 14% to 2% following application of Clindamycin.